Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acacia Clinics is a leading provider of accelerated transcranial magnetic stimulation (TMS) therapies for treatment-resistant depression, with a high reported response and remission rate. They are the most experienced commercial provider of SAINT® Therapy (a 5-day, MRI-guided, accelerated TMS protocol) in Northern California, having administered over 20,000 treatment sessions. Clinical trial data for SAINT® report a 79% remission rate in severe depression patients, and their broader TMS offerings show a 77% response rate. They are also conducting clinical trials investigating low-intensity ultrasound for generalized anxiety disorder.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acacia Clinics.